Hanall Biopharma Co., Ltd. (KRX:009420)
South Korea
· Delayed Price · Currency is KRW 49,550
-10,250 (-17.14%)
At close: Mar 4, 2026
32.49% (1Y)
| Market Cap | 3.04T |
| Revenue (ttm) | 154.05B |
| Net Income (ttm) | 2.31B |
| Shares Out | 50.78M |
| EPS (ttm) | 45.51 |
| PE Ratio | 1,314.38 |
| Forward PE | 383.17 |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 637,955 |
| Average Volume | 509,541 |
| Open | 55,500 |
| Previous Close | 59,800 |
| Day's Range | 49,200 - 57,100 |
| 52-Week Range | 24,000 - 64,000 |
| Beta | 0.84 |
| RSI | 65.88 |
| Earnings Date | Mar 6, 2026 |